SCHEMBL20866679

SCHEMBL20866679

N=C(NC1N=C(c2ccccc2)c2ccccc2NC1=O)OC(=N)c1ccncc1N1CCCCC1

nearest known ligand 0.51

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ CBLB Q13191 7/20 0.51
▸ CCKBR P32239 10/20 0.47
▸ CCKAR P32238 8/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20867053 0.94 CBLB (0.53) CBLBCCKBRCCKAR
SCHEMBL20866755 0.92 CBLB (0.59) CBLBCCKBRCCKAR
SCHEMBL24611936 0.90 CCKBR (0.53) CBLBCCKBRCCKAR
SCHEMBL20866622 0.86 CBLB (0.61) CBLBCCKBRCCKAR
SCHEMBL20866962 0.85 CCKBR (0.49) CBLBCCKBRCCKAR
SCHEMBL20867172 0.83 CBLB (0.56) CBLBCCKBRCCKAR
SCHEMBL20866674 0.83 CBLB (0.59) CBLBCCKBRCCKAR
SCHEMBL20866770 0.83 CCKAR (0.51) CBLBCCKBRCCKAR
SCHEMBL24611909 0.83 CBLB (0.59) CBLBCCKBRCCKAR
SCHEMBL24611988 0.82 CBLB (0.51) CBLBCCKBRCCKAR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3324977-B1 BENZODIAZEPINE DERIVATIVES AS RSV INHIBITORS ENANTA PHARM INC (US) 2022-07-13 — — EP disclosed
WO-2019067864-A1 COMBINATION PHARMACEUTICAL AGENTS AS RSV INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2019-04-04 — — WO disclosed
Send feedback